NADPH oxidases and vascular remodeling in cardiovascular diseases

Pharmacological Research

Volumn 114, Issue , 2016, Pages 110-120

  García Redondo, Ana B ^a   Aguado, Andrea ^a   Briones, Ana M ^a   Salaices, Mercedes ^a  

^a AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

Cardiovascular diseases; Cell migration; Cell proliferation; NOX 1; NOX 4; Reactive oxygen species; Vascular remodeling; Vascular smooth muscle cells

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 6; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 7; SCLEROPROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ISOPROTEIN;

ABDOMINAL AORTA ANEURYSM; AORTIC DILATION; APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; DISEASE ASSOCIATION; DNA MODIFICATION; ENZYME INHIBITION; ENZYME REGULATION; HEART VENTRICLE HYPERTROPHY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MARFAN SYNDROME; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PULMONARY HYPERTENSION; RESTENOSIS; REVIEW; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; VASCULITIS; ANIMAL; CELL MOTION; ENZYMOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; NADPH OXIDASE 1; NADPH OXIDASE 4; NADPH OXIDASES; PROTEIN ISOFORMS; REACTIVE OXYGEN SPECIES; VASCULAR REMODELING;

EID: 84994059928     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.10.015     Document Type: Review

References (167)

1. [1] Drummond, G.R., Selemidis, S., Griendling, K.K., Sobey, C.G., Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10 (2011), 453–471.
2. [2] Lassègue, B., San Martín, A., Griendling, K.K., Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res. 110 (2012), 1364–1390.
3. [3] Schröder, K., NADPH oxidases in redox regulation of cell adhesion and migration. Antioxid. Redox Signal. 20 (2014), 2043–2058.
4. [4] McMaster, W.G., Kirabo, A., Madhur, M.S., Harrison, D.G., Inflammation, immunity, and hypertensive end-organ damage. Circ. Res. 116 (2015), 1022–1033.
5. [5] Caillon, A., Schiffrin, E.L., Role of inflammation and immunity in hypertension: recent epidemiological, laboratory, and clinical evidence. Curr. Hypertens. Rep., 18, 2016, 21.
6. [6] Gibbons, G.H., Dzau, V.J., The emerging concept of vascular remodeling. N. Engl. J. Med. 330 (1994), 1431–1438.
7. [7] McGrath, J.C., Deighan, C., Briones, A.M., Shafaroudi, M.M., McBride, M., Adler, J., Arribas, S.M., Vila, E., Daly, C.J., New aspects of vascular remodelling: the involvement of all vascular cell types. Exp. Physiol. 90 (2005), 469–475.
8. [8] Briones, A.M., Arribas, S.M., Salaices, M., Role of extracellular matrix in vascular remodeling of hypertension. Curr. Opin. Nephrol. Hypertens. 19 (2010), 187–194.
9. [9] Renna, N.F., de las Heras, N., Miatello, R.M., Pathophysiology of vascular remodeling in hypertension. Int. J. Hypertens., 2013, 2013, 808353.
10. [10] Intengan, H.D., Schiffrin, E.L., Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38 (2001), 581–587.
11. [11] Mulvany, M.J., Baumbach, G.L., Aalkjaer, C., Heagerty, A.M., Korsgaard, N., Schiffrin, E.L., Heistad, D.D., Vascular remodeling. Hypertension 28 (1996), 505–506.
12. [12] Schiffrin, E.L., Vascular remodeling in hypertension: mechanisms and treatment. Hypertension 59 (2012), 367–374.
13. [13] Aguado, A., Rodríguez, C., Martínez-Revelles, S., Avendaño, M.S., Zhenyukh, O., Orriols, M., Martínez-González, J., Alonso, M.J., Briones, A.M., Dixon, D.A., Salaices, M., HuR mediates the synergistic effects of angiotensin II and IL-1 (on vascular COX-2 expression and cell migration. Br. J. Pharmacol. 172 (2015), 3028–3042.
14. [14] Virdis, A., Colucci, R., Neves, M.F., Rugani, I., Aydinoglu, F., Fornai, M., Ippolito, C., Antonioli, L., Duranti, E., Solini, A., Bernardini, N., Blandizzi, C., Taddei, S., Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition. Eur. Heart J. 33 (2012), 2225–2234.
15. [15] Briones, A.M., Aras-López, R., Alonso, M.J., Salaices, M., Small artery remodeling in obesity and insulin resistance. Curr. Vasc. Pharmacol. 12 (2014), 427–437.
16. [16] Rizzoni, D., Porteri, E., Guelfi, D., Muiesan, M.L., Valentini, U., Cimino, A., Girelli, A., Rodella, L., Bianchi, R., Sleiman, I., Rosei, E.A., Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 103 (2001), 1238–1244.
17. [17] Endemann, D.H., Pu, Q., De Ciuceis, C., Savoia, C., Virdis, A., Neves, M.F., Touyz, R.M., Schiffrin, E.L., Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension 43 (2004), 399–404.
18. [18] Nørrelund, H., Christensen, K.L., Samani, N.J., Kimber, P., Mulvany, M.J., Korsgaard, N., Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 24 (1994), 301–308.
19. [19] Briones, A.M., Xavier, F.E., Arribas, S.M., González, M.C., Rossoni, L.V., Alonso, M.J., Salaices, M., Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 291 (2006), H193–201.
20. [20] Chandesris, M.O., Azarine, A., Ong, K.T., Taleb, S., Boutouyrie, P., Mousseaux, E., Romain, M., Bozec, E., Laurent, S., Boddaert, N., Thumerelle, C., Tillie-Leblond, I., Hoarau, C., Lebranchu, Y., Aladjidi, N., Tron, F., Barlogis, V., Body, G., Munzer, M., Jaussaud, R., Suarez, F., Clément, O., Hermine, O., Tedgui, A., Lortholary, O., Picard, C., Mallat, Z., Fischer, A., Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency. Circ. Cardiovasc. Genet. 5 (2012), 25–34.
21. [21] Bakker, E.N., van der Meulen, E.T., van den Berg, B.M., Everts, V., Spaan, J.A., VanBavel, E., Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J. Vasc. Res. 39 (2002), 12–20.
22. [22] Schiffrin, E.L., Deng, L.Y., Larochelle, P., Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin. Invest. Med. 16 (1993), 177–186.
23. [23] Schiffrin, E.L., Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am. J. Hypert. 17 (2004), 1192–1200.
24. [24] Briones, A.M., González, J.M., Somoza, B., Giraldo, J., Daly, C.J., Vila, E., González, M.C., McGrath, J.C., Arribas, S.M., Role of elastin in spontaneously hypertensive rat small mesenteric artery remodelling. J. Physiol. 552 (2003), 185–195.
25. [25] Briones, A.M., Rodríguez-Criado, N., Hernanz, R., García-Redondo, A.B., Rodrigues-Díez, R.R., Alonso, M.J., Egido, J., Ruiz-Ortega, M., Salaices, M., Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. Hypertension 54 (2009), 142–149.
26. [26] Colucci, R., Fornai, M., Duranti, E., Antonioli, L., Rugani, I., Aydinoglu, F., Ippolito, C., Segnani, C., Bernardini, N., Taddei, S., Blandizzi, C., Virdis, A., Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1. Br. J. Pharmacol. 169 (2013), 554–566.
27. [27] Rizzoni, D., Porteri, E., Boari, G.E., De Ciuceis, C., Sleiman, I., Muiesan, M.L., Castellano, M., Miclini, M., Agabiti-Rosei, E., Prognostic significance of smallartery structure in hypertension. Circulation 108 (2003), 2230–2235.
28. [28] Mathiassen, O.N., Buus, N.H., Sihm, I., Thybo, N.K., Mørn, B., Schroeder, A.P., Thygesen, K., Aalkjaer, C., Lederballe, O., Mulvany, M.J., Christensen, K.L., Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J. Hypertens. 25 (2007), 1021–1026.
29. [29] Rizzoni, D., Agabiti-Rosei, E., Structural abnormalities of small resistance arteries in essential hypertension. Intern. Emerg. Med. 7 (2012), 205–212.
30. [30] Fuster, J.J., Fernández, P., González-Navarro, H., Silvestre, C., Nabah, Y.N., Andrés, V., Control of cell proliferation in atherosclerosis: insights from animal models and human studies. Cardiovasc. Res. 86 (2010), 254–264.
31. [31] Van Varik, B.J., Rennenberg, R.J., Reutelingsperger, C.P., Kroon, A.A., de Leeuw, P.W., Schurgers, L.J., Mechanisms of arterial remodeling: lessons from genetic diseases. Front. Genet., 3, 2012, 290.
32. [32] Laurent, S., Boutouyrie, P., The structural factor of hypertension: large and small artery alterations. Circ. Res. 116 (2015), 1007–1021.
33. [33] Shimizu, K., Mitchell, R.N., Libby, P., Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 26 (2006), 987–994.
34. [34] Montezano, A.C., Tsiropoulou, S., Dulak-Lis, M., Harvey, A., Camargo Lde, L., Touyz, R.M., Redox signaling, Nox5 and vascular remodeling in hypertension. Curr. Opin. Nephrol. Hypertens. 24 (2015), 425–433.
35. [35] Brown, D.I., Griendling, K.K., Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ. Res. 116 (2015), 531–549.
36. [36] Karimi Galougahi, K., Ashley, E.A., Ali, Z.A., Redox regulation of vascular remodeling. Cell. Mol. Life Sci. 73 (2016), 349–363.
37. [37] Owens, G.K., Kumar, M.S., Wamhoff, B.R., Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84 (2004), 767–801.
38. [38] Zhang, M.J., Zhou, Y., Chen, L., Wang, Y.Q., Wang, X., Pi, Y., Gao, C.Y., Li, J.C., Zhang, L.L., An overview of potential molecular mechanisms involved in VSMC phenotypic modulation. Histochem. Cell Biol. 145 (2016), 119–130.
39. [39] Althoff, T.F., Offermanns, S., G-protein-mediated signaling in vascular smooth muscle cells − implications for vascular disease. J. Mol. Med. (Berl.) 93 (2015), 973–981.
40. [40] Guignabert, C., Tu, L., Girerd, B., Ricard, N., Huertas, A., Montani, D., Humbert, M., New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication. Chest 147 (2015), 529–537.
41. [41] Li, M.X., Jiang, D.Q., Wang, Y., Chen, Q.Z., Ma, Y.J., Yu, S.S., Wang, Y., Signal mechanisms of vascular remodeling in the development of pulmonary arterial hypertension. J. Cardiovasc. Pharmacol. 67 (2016), 182–190.
42. [42] Newby, A.C., Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc. Res. 69 (2006), 614–624.
43. [43] Kumar, A., Lindner, V., Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler. Thromb. Vasc. Biol. 17 (1997), 2238–2244.
44. [44] Kawasaki, T., Dewerchin, M., Lijnen, H.R., Vreys, I., Vermylen, J., Hoylaerts, M.F., Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development. Circ. Res. 88 (2001), 159–166.
45. [45] Roque, F.R., Briones, A.M., García-Redondo, A.B., Galán, M., Martínez-Revelles, S., Avendaño, M.S., Cachofeiro, V., Fernandes, T., Vassallo, D.V., Oliveira, E.M., Salaices, M., Aerobic exercise reduces oxidative stress and improves vascular changes of small mesenteric and coronary arteries in hypertension. Br. J. Pharmacol. 168 (2013), 686–703.
46. [46] Ozasa, Y., Akazawa, H., Qin, Y., Tateno, K., Ito, K., Kudo-Sakamoto, Y., Yano, M., Yabumoto, C., Naito, A.T., Oka, T., Lee, J.K., Minamino, T., Nagai, T., Kobayashi, Y., Komuro, I., Notch activation mediates angiotensin II-induced vascular remodeling by promoting the proliferation and migration of vascular smooth muscle cells. Hypertens. Res. 36 (2013), 859–865.
47. [47] Valente, A.J., Yoshida, T., Murthy, S.N., Sakamuri, S.S., Katsuyama, M., Clark, R.A., Delafontaine, P., Chandrasekar, B., Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18. Am. J. Physiol. Heart Circ. Physiol. 303 (2012), H282–96.
48. [48] Hernanz, R., Martínez-Revelles, S., Palacios, R., Martín, A., Cachofeiro, V., Aguado, A., García-Redondo, L., Barrús, M.T., de Batista, P.R., Briones, A.M., Salaices, M., Alonso, M.J., Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension. Br. J. Pharmacol. 172 (2015), 3159–3176.
49. [49] Schiffrin, E.L., Immune mechanisms in hypertension and vascular injury. Clin. Sci. (Lond.) 126 (2014), 267–274.
50. [50] Aggarwal, S., Gross, C.M., Sharma, S., Fineman, J.R., Black, S.M., Reactive oxygen species in pulmonary vascular remodeling. Compr. Physiol. 3 (2013), 1011–1034.
51. [51] Emeto, T., Moxon, J.V., Au, M., Golledge, J., Oxidative stress and abdominal aortic aneurysm: potential treatment targets. Clin. Sci. (Lond.) 130 (2016), 301–315.
52. [52] Meng, X., Yang, J., Dong, M., Zhang, K., Tu, E., Gao, Q., Chen, W., Zhang, C., Regulatory, Zhang Y., T cells in cardiovascular diseases. Nat. Rev. Cardiol. 13 (2016), 167–179.
53. [53] Peshkova, I.O., Schaefer, G., Koltsova, E.K., Atherosclerosis and aortic aneurysm − is inflammation a common denominator?. FEBS J. 283 (2016), 1636–1652.
54. [54] Touyz, R.M., Briones, A.M., Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens. Res. 34 (2011), 5–14.
55. [55] Montezano, A.C., Touyz, R.M., Reactive oxygen species, vascular noxs, and hypertension: focus on translational and clinical research. Antioxid. Redox Signal. 20 (2014), 164–182.
56. [56] Hernanz, R., Briones, A.M., Salaices, M., Alonso, M.J., New roles for old pathways? A circuitous relationship between reactive oxygen species and cyclo-oxygenase in hypertension. Clin. Sci. (Lond.) 126 (2014), 111–121.
57. [57] Dikalov, S.I., Cross talk between mitochondria and NADPH oxidases. Free Radic. Biol. Med. 51 (2011), 1289–1301.
58. [58] Lacy, F., Gough, D.A., Schmid-Schönbein, G.W., Role of xanthine oxidase in hydrogen peroxide production. Free Radic. Biol. Med. 25 (1998), 720–727.
59. [59] Schulz, E., Jansen, T., Wenzel, P., Daiber, A., Münzel, T., Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid. Redox Signal. 10 (2008), 1115–1126.
60. [60] Martínez-Revelles, S., Avendaño, M.S., García-Redonodo, A.B., Alvarez, Y., Aguado, A., Pérez-Girón, J.V., García-Redondo, L., Esteban, V., Redondo, J.M., Alonso, M.J., Briones, A.M., Salaices, M., Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. Antioxid. Redox Signal. 18 (2013), 51–65.
61. [61] Virdis, A., Taddei, S., Endothelial dysfunction in resistance arteries of hypertensive humans: old and new conspirators. J. Cardiovasc. Pharmacol. 67 (2016), 451–457.
62. [62] Al Ghouleh, I., Frazziano, G., Rodriguez, A.I., Csányi, G., Maniar, S., St Croix, C.M., Kelley, E.E., Egaña, L.A., Song, G.J., Bisello, A., Lee, Y.J., Pagano, P.J., Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy. Cardiovasc. Res. 97 (2013), 134–142.
63. [63] Ebrahimian, T., Touyz, R.M., Thioredoxin in vascular biology: role in hypertension. Antioxid. Redox Signal. 10 (2008), 1127–1136.
64. [64] Bretón-Romero, R., Lamas, S., Hydrogen peroxide signaling in vascular endothelial cells. Redox Biol. 2 (2014), 529–534.
65. [65] Brandes, R.P., Weissmann, N., Schröder, K., Redox-mediated signal transduction by cardiovascular Nox NADPH oxidases. J. Mol. Cell. Cardiol. 73 (2014), 70–79.
66. [66] Finkel, T., Signal transduction by reactive oxygen species. J. Cell Biol. 194 (2011), 7–15.
67. [67] Tanner, J.J., Parsons, Z.D., Cummings, A.H., Zhou, H., Gates, K.S., Redox regulation of protein tyrosine phosphatases: structural and chemical aspects. Antioxid. Redox Signal. 15 (2011), 77–97.
68. [68] Briones, A.M., Touyz, R.M., Oxidative stress and hypertension: current concepts. Curr. Hypertens. Rep. 12 (2010), 135–142.
69. [69] Stanley, A., Thompson, K., Hynes, A., Brakebusch, C., Quondamatteo, F., NADPH oxidase complex-derived reactive oxygen species, the actin cytoskeleton, and rho GTPases in cell migration. Antioxid. Redox Signal. 20 (2014), 2026–2042.
70. [70] Pimentel, D., Haeussler, D.J., Matsui, R., Burgoyne, J.R., Cohen, R.A., Bachschmid, M.M., Regulation of cell physiology and pathology by protein S-glutathionylation: lessons learned from the cardiovascular system. Antioxid. Redox Signal. 16 (2012), 524–542.
71. [71] Konior, A., Schramm, A., Czesnikiewicz-Guzik, M., Guzik, T.J., NADPH oxidases in vascular pathology. Antioxid. Redox Signal. 20 (2014), 2794–2814.
72. [72] Lyle, A.N., Deshpande, N.N., Taniyama, Y., Seidel-Rogol, B., Pounkova, L., Du, P., Papaharalambus, C., Lassègue, B., Griendling KK. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ. Res. 105 (2009), 249–259.
73. [73] Chen, F., Haigh, S., Barman, S., Fulton, D.J.R., From form to function: the role of Nox4 in the cardiovascular system. Front. Physiol., 3, 2012, 412.
74. [74] Vendrov, A.E., Vendrov, K.C., Smith, A., Yuan, J., Sumida, A., Robidoux, J., Runge, M.S., Madamanchi, N.R., NOX4 NADPH oxidase-dependent mitochondrial oxidative stress in aging-associated cardiovascular disease. Antioxid. Redox Signal. 23 (2015), 1389–1409.
75. [75] Manea, S.A., Constantin, A., Manda, G., Sasson, S., Manea, A., Regulation of Nox enzymes expression in vascular pathophysiology: focusing on transcription factors and epigenetic mechanisms. Redox Biol. 5 (2015), 358–366.
76. [76] Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q.Q., Akers, M., Zhang, Y., Grant, S.L., Lambeth, J.D., Griendling, K.K., Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88 (2001), 888–894.
77. [77] Briones, A.M., Tabet, F., Callera, G.E., Montezano, A.C., Yogi, A., He, Y., Quinn, M.T., Salaices, M., Touyz, R.M., Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. J. Am. Soc. Hypertens. 5 (2011), 137–153.
78. [78] Aguado, A., Fischer, T., Rodríguez, C., Manea, A., Martínez-González, J., Touyz, R.M., Hernanz, R., Alonso, M.J., Dixon, D.A., Briones, A.M., Salaices, M., Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells. J. Hypertens. 34 (2016), 253–265.
79. [79] Katsuyama, M., Fan, C., Arakawa, N., Nishinaka, T., Miyagishi, M., Taira, K., Yabe-Nishimura, C., Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain. Biochem. J 386 (2005), 255–261.
80. [80] Manea, A., Tanase, L.I., Raicu, M., Simionescu, M., JAK/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 105–112.
81. [81] Martín, A., Perez-Girón, J.V., Hernanz, R., Palacios, R., Briones, A.M., Fortuño, A., Zalba, G., Salaices, M., Alonso, M.J., Peroxisome proliferator-activated receptor- (activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress. J. Hypertens. 30 (2012), 315–326.
82. [82] Wang, P., Tang, F., Li, R., Zhang, H., Chen, S., Liu, P., Huang, H., Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan. Pharmacol. Res. 55 (2007), 408–417.
83. [83] Nakano, D., Kurumazuka, D., Nagai, Y., Nishiyama, A., Kiso, Y., Matsumura, Y., Dietary sesamin suppresses aortic NADPH oxidase in DOCA salt hypertensive rats. Clin. Exp. Pharmacol. Physiol. 35 (2008), 324–326.
84. [84] Wingler, K., Wünsch, S., Kreutz, R., Rothermund, L., Paul, M., Schmidt, H.H., Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic. Biol. Med. 31 (2001), 1456–1464.
85. [85] Akasaki, T., Ohya, Y., Kuroda, J., Eto, K., Abe, I., Sumimoto, H., Iida, M., Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: involvement of the renin-angiotensin system. Hypertens. Res. 29 (2006), 813–820.
86. [86] Hood, K.Y., Montezano, A.C., Harvey, A.P., Nilsen, M., MacLean, M.R., Touyz, R.M., Nicotinamide adenine dinucleotide phosphate oxidase-mediated redox signaling and vascular remodeling by 16α-hydroxyestrone in human pulmonary artery cells: implications in pulmonary arterial hypertension. Hypertension, 2016 (pii: HYPERTENSIONAHA.116.07668).
87. [87] Veit, F., Pak, O., Egemnazarov, B., Roth, M., Kosanovic, D., Seimetz, M., Sommer, N., Ghofrani, H.A., Seeger, W., Grimminger, F., Brandes, R.P., Schermuly, R.T., Weissmann, N., Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling. Antioxid. Redox Signal. 19 (2013), 2213–2231.
88. [88] Szöcs, K., Lassègue, B., Sorescu, D., Hilenski, L.L., Valppu, L., Couse, T.L., Wilcox, J.N., Quinn, M.T., Lambeth, J.D., Griendling, K.K., Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler. Thromb. Vasc. Biol. 22 (2002), 21–27.
89. [89] Paravicini, T.M., Gulluyan, L.M., Dusting, G.J., Drummond, G.R., Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ. Res. 91 (2002), 54–61.
90. [90] Sorescu, D., Weiss, D., Lassègue, B., Clempus, R.E., Szocs, K., Sorescu, G.P., Valppu, L., Quinn, M.T., Lambeth, J.D., Vega, J.D., Taylor, W.R., Griendling, K.K., Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105 (2002), 1429–1435.
91. [91] Kalinina, N., Agrotis, A., Tararak, E., Antropova, Y., Kanellakis, P., Ilyinskaya, O., Quinn, M.T., Smirnov, V., Bobik, A., Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 22 (2002), 2037–2043.
92. [92] Gray, S.P., Di Marco, E., Kennedy, K., Chew, P., Okabe, J., El-Osta, A., Calkin, A.C., Biessen, E.A., Touyz, R.M., Cooper, M.E., Schmidt, H.H., Jandeleit-Dahm, K.A., Reactive oxygen species can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 36 (2016), 295–307.
93. [93] Cevik, M.O., Katsuyama, M., Kanda, S., Kaneko, T., Iwata, K., Ibi, M., Matsuno, K., Kakehi, T., Cui, W., Sasaki, M., Yabe-Nishimura, C., The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: possible involvement of the ERK1/2-JunB pathway. Biochem. Biophys. Res. Commun. 374 (2008), 351–355.
94. [94] Manea, A., Tanase, L.I., Raicu, M., Simionescu, M., Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 396 (2010), 901–907.
95. [95] Dikalov, S.I., Dikalova, A.E., Bikineyeva, A.T., Schmidt, H.H., Harrison, D.G., Griendling, K.K., Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic. Biol. Med. 45 (2008), 1340–1351.
96. [96] Takac, I., Schröder, K., Zhang, L., Lardy, B., Anilkumar, N., Lambeth, J.D., Shah, A.M., Morel, F., Brandes, R.P., The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 286 (2011), 13304–13313.
97. [97] Mittal, M., Roth, M., König, P., Hofmann, S., Dony, E., Goyal, P., Selbitz, A.C., Schermuly, R.T., Ghofrani, H.A., Kwapiszewska, G., Kummer, W., Klepetko, W., Hoda, M.A., Fink, L., Hänze, J., Seeger, W., Grimminger, F., Schmidt, H.H., Weissmann, N., Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ. Res. 101 (2007), 258–267.
98. [98] Diebold, I., Petry, A., Hess, J., Görlach, A., The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol. Biol. Cell 21 (2010), 2087–2096.
99. [99] Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P.J., Ariyan, S., Dikalov, S., Sorescu, D., NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97 (2005), 900–907.
100. [100] Sturrock, A., Cahill, B., Norman, K., Huecksteadt, T.P., Hill, K., Sanders, K., Karwande, S.V., Stringham, J.C., Bull, D.A., Gleich, M., Kennedy, T.P., Hoidal, J.R., Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290 (2006), L661–73.
101. [101] Sturrock, A., Huecksteadt, T.P., Norman, K., Sanders, K., Murphy, T.M., Chitano, P., Wilson, K., Hoidal, J.R., Kennedy, T.P., Nox4 mediates TGF-beta1-induced retinoblastoma protein phosphorylation, proliferation, and hypertrophy in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 292 (2007), L1543–55.
102. [102] Ellmark, S.H.M., Dusting, G.J., Tang Fui, M.N., Guzzo-Pernell, N., Drummond, G.R., The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc. Res. 65 (2005), 495–504.
103. [103] Hwang, J., Kleinhenz, D.J., Lassègue, B., Griendling, K.K., Dikalov, S., Hart, C.M., Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am. J. Physiol. Cell Physiol. 288 (2005), C899–905.
104. [104] Wind, S., Beuerlein, K., Armitage, M.E., Taye, A., Kumar, A.H., Janowitz, D., Neff, C., Shah, A.M., Wingler, K., Schmidt, H.H., Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension 56 (2010), 490–497.
105. [105] Paravicini, T.M., Chrissobolis, S., Drummond, G.R., Sobey, C.G., Increased NADPH oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke 35 (2004), 584–589.
106. [106] Mollnau, H., Wendt, M., Szöcs, K., Lassègue, B., Schulz, E., Oelze, M., Li, H., Bodenschatz, M., August, M., Kleschyov, A.L., Tsilimingas, N., Walter, U., Förstermann, U., Meinertz, T., Griendling, K., Münzel, T., Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90 (2002), E58–65.
107. [107] Nishiyama, A., Yao, L., Nagai, Y., Miyata, K., Yoshizumi, M., Kagami, S., Kondo, S., Kiyomoto, H., Shokoji, T., Kimura, S., Kohno, M., Abe, Y., Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 43 (2004), 841–848.
108. [108] Jarman, E.R., Khambata, V.S., Cope, C., Jones, P., Roger, J., Ye, L.Y., Duggan, N., Head, D., Pearce, A., Press, N.J., Bellenie, B., Sohal, B., Jarai, G., An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model. Am. J. Respir. Cell Mol. Biol. 50 (2014), 158–169.
109. [109] Guzik, B., Sagan, A., Ludew, D., Mrowiecki, W., Chwała, M., Bujak-Gizycka, B., Filip, G., Grudzien, G., Kapelak, B., Zmudka, K., Mrowiecki, T., Sadowski, J., Korbut, R., Guzik, T.J., Mechanisms of oxidative stress in human aortic aneurysms–association with clinical risk factors for atherosclerosis and disease severity. Int. J. Cardiol. 168 (2013), 2389–2396.
110. [110] Judkins, C.P., Diep, H., Broughton, B.R., Mast, A.E., Hooker, E.U., Miller, A.A., Selemidis, S., Dusting, G.J., Sobey, C.G., Drummond, G.R., Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/-mice. Am. J. Physiol. Heart Circ. Physiol. 298 (2010), H24–32.
111. [111] Stanic, B., Pandey, D., Fulton, D.J., Miller, F.J. Jr, Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32 (2012), 2452–2460.
112. [112] Katsuyama, M., Matsuno, K., Yabe-Nishimura, C., Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme. J Clin Biochem Nutr 50 (2012), 9–22.
113. [113] Zhang, L., Sheppard, O.R., Shah, A.M., Brewer, A.C., Positive regulation of the NADPH oxidase NOX4 promoter in vascular smooth muscle cells by E2F. Free Radic. Biol. Med. 45 (2008), 679–685.
114. [114] Katsuyama, M., Hirai, H., Iwata, K., Ibi, M., Matsuno, K., Matsumoto, M., Yabe-Nishimura, C., Sp3 transcription factor is crucial for transcriptional activation of the human NOX4 gene. FEBS J. 278 (2011), 964–972.
115. [115] Siuda, D., Zechner, U., El Hajj, N., Prawitt, D., Langer, D., Xia, N., Horke, S., Pautz, A., Kleinert, H., Förstermann, U., Li, H., Transcriptional regulation of Nox4 by histone deacetylases in human endothelial cells. Basic Res. Cardiol., 107, 2012, 283.
116. [116] Paneni, F., Osto, E., Costantino, S., Mateescu, B., Briand, S., Coppolino, G., Perna, E., Mocharla, P., Akhmedov, A., Kubant, R., Rohrer, L., Malinski, T., Camici, G.G., Matter, C.M., Mechta-Grigoriou, F., Volpe, M., Lüscher, T.F., Cosentino, F., Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunction. Circulation 127 (2013), 1229–1240 e1–e21.
117. [117] Varga, Z.V., Kupai, K., Szűcs, G., Gáspár, R., Pálóczi, J., Faragó, N., Zvara, A., Puskás, L.G., Rázga, Z., Tiszlavicz, L., Bencsik, P., Görbe, A., Csonka, C., Ferdinandy, P., Csont, T., MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart. J. Mol. Cell. Cardiol. 62 (2013), 111–121.
118. [118] Peshavariya, H., Jiang, F., Taylor, C.J., Selemidis, S., Chang, C.W., Dusting, G.J., Translation-linked mRNA destabilization accompanying serum-induced Nox4 expression in human endothelial cells. Antioxid. Redox Signal. 11 (2009), 2399–2408.
119. [119] Bruder-Nascimento, T., Chinnasamy, P., Riascos-Bernal, D.F., Cau, S.B., Callera, G.E., Touyz, R.M., Tostes, R.C., Sibinga, N.E., Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. J. Mol. Cell. Cardiol. 66 (2014), 18–26.
120. [120] Park, J.B., Touyz, R.M., Chen, X., Schiffrin, E.L., Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am. J. Hypertens. 15 (2002), 78–84.
121. [121] Virdis, A., Neves, M.F., Amiri, F., Touyz, R.M., Schiffrin, E.L., Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J. Hypertens. 22 (2004), 535–542.
122. [122] Chen, Q.Z., Han, W.Q., Chen, J., Zhu, D.L., Chen-Yan Gao, P.J., Anti-stiffness effect of apocynin in deoxycorticosterone acetate-salt hypertensive rats via inhibition of oxidative stress. Hypertens. Res. 36 (2013), 306–312.
123. [123] McCormick, M., Gavrila, D., Weintraub, N., Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 461–469.
124. [124] Goncharov, N.V., Avdonin, P.V., Nadeev, A.D., Zharkikh, I.L., Jenkins, R.O., Reactive oxygen species in pathogenesis of atherosclerosis. Curr. Pharm. Des. 21 (2015), 1134–1146.
125. [125] Schröder, K., Helmcke, I., Palfi, K., Krause, K.H., Busse, R., Brandes, R.P., Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 1736–1743.
126. [126] Lee, M.Y., San Martin, A., Mehta, P.K., Dikalova, A.E., Garrido, A.M., Datla, S.R., Lyons, E., Krause, K.H., Banfi, B., Lambeth, J.D., Lassègue, B., Griendling, K.K., Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 480–487.
127. [127] Suh, Y.A., Arnold, R.S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A.B., Griendling, K.K., Lambeth, J.D., Cell transformation by the superoxide-generating oxidase mox1. Nature 401 (1999), 79–82.
128. [128] Wang, X., Sun, Z., Thyroid hormone induces artery smooth muscle cell proliferation: discovery of a new tralpha1-nox1 pathway. J. Cell. Mol. Med. 14 (2010), 368–380.
129. [129] Rodríguez, A.I., Csányi, G., Ranayhossaini, D.J., Feck, D.M., Blose, K.J., Assatourian, L., Vorp, D.A., Pagano, P.J., MEF2B-Nox1 signaling is critical for stretch-induced phenotypic modulation of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 430–438.
130. [130] Gavazzi, G., Banfi, B., Deffert, C., Fiette, L., Schappi, M., Herrmann, F., Krause, K.H., Decreased blood pressure in NOX1-deficient mice. FEBS Lett. 580 (2006), 497–504.
131. [131] Schröder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J., Kruse, C., Luedike, P., Michaelis, U.R., Weissmann, N., Dimmeler, S., Shah, A.M., Brandes, R.P., Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ. Res. 110 (2012), 1217–1225.
132. [132] Matsuno, K., Yamada, H., Iwata, K., Jin, D., Katsuyama, M., Matsuki, M., Takai, S., Yamanishi, K., Miyazaki, M., Matsubara, H., Yabe-Nishimura, C., Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 (2005), 2677–2685.
133. [133] Dikalova, A., Clempus, R., Lassègue, B., Cheng, G., McCoy, J., Dikalov, S., San Martin, A., Lyle, A., Weber, D.S., Weiss, D., Taylor, W.R., Schmidt, H.H., Owens, G.K., Lambeth, J.D., Griendling, K.K., Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112 (2005), 2668–2676.
134. [134] Gavazzi, G., Deffert, C., Trocme, C., Schäppi, M., Herrmann, F.R., Krause, K.H., NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 50 (2007), 189–196.
135. [135] Wilkinson-Berka, J.L., Deliyanti, D., Rana, I., Miller, A.G., Agrotis, A., Armani, R., Szyndralewiez, C., Wingler, K., Touyz, R.M., Cooper, M.E., Jandeleit-Dahm, K.A., Schmidt, H.H., NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy. Antioxid. Redox Signal. 20 (2014), 2726–2740.
136. [136] Sheehan, A.L., Carrell, S., Johnson, B., Stanic, B., Banfi, B., Miller, F.J., Role for Nox1 NADPH oxidase in atherosclerosis. Atherosclerosis 216 (2011), 321–326.
137. [137] Sobey, C.G., Judkins, C.P., Rivera, J., Lewis, C.V., Diep, H., Lee, H.W., Kemp-Harper, B.K., Broughton, B.R., Selemidis, S., Gaspari, T.A., Samuel, C.S., Drummond, G.R., NOX1 deficiency in apolipoprotein E-knockout mice is associated with elevated plasma lipids and enhanced atherosclerosis. Free Radic. Res. 49 (2015), 186–198.
138. [138] Gray, S.P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A.C., de Haan, J.B., Koulis, C., El-Osta, A., Andrews, K.L., Chin-Dusting, J.P., Touyz, R.M., Wingler, K., Cooper, M.E., Schmidt, H.H., Jandeleit-Dahm, K.A., NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation 127 (2013), 1888–1902.
139. [139] Datla, S.R., McGrail, D.J., Vukelic, S., Huff, L.P., Lyle, A.N., Pounkova, L., Lee, M., Seidel-Rogol, B., Khalil, M.K., Hilenski, L.L., Terada, L.S., Dawson, M.R., Lassègue, B., Griendling, K.K., Poldip2 controls vascular smooth muscle cell migration by regulating focal adhesion turnover and force polarization. Am. J. Physiol. Heart Circ. Physiol. 307 (2014), H945–57.
140. [140] Clempus, R.E., Sorescu, D., Dikalova, A.E., Pounkova, L., Jo, P., Sorescu, G.P., Schmidt, H.H., Lassègue, B., Griendling, K.K., Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 42–48.
141. 2. Am. J. Physiol. Cell Physiol. 296 (2009), C711–23.
142. [142] Pedruzzi, E., Guichard, C., Ollivier, V., Driss, F., Fay, M., Prunet, C., Marie, J.C., Pouzet, C., Samadi, M., Elbim, C., O'Dowd, Y., Bens, M., Vandewalle, A., Gougerot-Pocidalo, M.A., Lizard, G., Ogier-Denis, E., NAD(P)H oxidase nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol. Cell. Biol. 24 (2004), 10703–10717.
143. [143] Craige, S.M., Kant, S., Reif, M., Chen, K., Pei, Y., Angoff, R., Sugamura, K., Fitzgibbons, T., Keaney, J.F. Jr., Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions. Free Radic. Biol. Med. 89 (2015), 1–7.
144. [144] Schürmann, C., Rezende, F., Kruse, C., Yasar, Y., Löwe, O., Fork, C., van de Sluis, B., Bremer, R., Weissmann, N., Shah, A.M., Jo, H., Brandes, R.P., Schröder, K., The NADPH oxidase Nox4 has anti-atherosclerotic functions. Eur. Heart J. 36 (2015), 3447–3456.
145. [145] Langbein, H., Brunssen, C., Hofmann, A., Cimalla, P., Brux, M., Bornstein, S.R., Deussen, A., Koch, E., Morawietz, H., NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice. Eur. Heart J. 37 (2016), 1753–1761.
146. [146] Di Marco, E., Gray, S.P., Kennedy, K., Szyndralewiez, C., Lyle, A.N., Lassègue, B., Griendling, K.K., Cooper, M.E., Schmidt, H.H., Jandeleit-Dahm, K.A., NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis. Free Radic. Biol. Med. 97 (2016), 556–567.
147. [147] Ago, T., Kuroda, J., Pain, J., Fu, C., Li, H., Sadoshima, J., Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ. Res. 106 (2010), 1253–1264.
148. [148] Zhang, M., Brewer, A.C., Schröder, K., Santos, C.X., Grieve, D.J., Wang, M., Anilkumar, N., Yu, B., Dong, X., Walker, S.J., Brandes, R.P., Shah, A.M., NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 18121–18126.
149. [149] Smyrnias, I., Zhang, X., Zhang, M., Murray, T.V., Brandes, R.P., Schröder, K., Brewer, A.C., Shah, A.M., Nicotinamide adenine dinucleotide phosphate oxidase-4-dependent upregulation of nuclear factor erythroid-derived 2-like 2 protects the heart during chronic pressure overload. Hypertension 65 (2015), 547–553.
150. [150] Tong, X., Hou, X., Jourd'heuil, D., Weisbrod, R.M., Cohen, R.A., Upregulation of Nox4 by TGF{beta}1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat. Circ. Res. 107 (2010), 975–983.
151. [151] Tong, X., Khandelwal, A.R., Qin, Z., Wu, X., Chen, L., Ago, T., Sadoshima, J., Cohen, R.A., Role of smooth muscle Nox4-based NADPH oxidase in neointimal hyperplasia. J. Mol. Cell. Cardiol. 89 (2015), 185–194.
152. [152] Onetti, Y., Meirelles, T., Dantas, A.P., Schröder, K., Vila, E., Egea, G., Jiménez-Altayó, F., NADPH oxidase 4 attenuates cerebral artery changes during the progression of Marfan syndrome. Am. J. Physiol. Heart Circ. Physiol. 310 (2016), H1081–90.
153. [153] Barman, S.A., Chen, F., Su, Y., Dimitropoulou, C., Wang, Y., Catravas, J.D., Han, W., Orfi, L., Szantai-Kis, C., Keri, G., Szabadkai, I., Barabutis, N., Rafikova, O., Rafikov, R., Black, S.M., Jonigk, D., Giannis, A., Asmis, R., Stepp, D.W., Ramesh, G., Fulton, D.J., NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 1704–1715.
154. [154] Green, D.E., Murphy, T.C., Kang, B.Y., Kleinhenz, J.M., Szyndralewiez, C., Page, P., Sutliff, R.L., Hart, C.M., The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. Am. J. Respir. Cell Mol. Biol. 47 (2012), 718–726.
155. [155] Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T.R., Horowitz, J.C., Pennathur, S., Martinez, F.J., Thannickal, V.J., NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 15 (2009), 1077–1081.
156. [156] Bernard, K., Hecker, L., Luckhardt, T.R., Cheng, G., Thannickal, V.J., NADPH oxidases in lung health and disease. Antioxid. Redox Signal. 20 (2014), 2838–2853.
157. [157] Liu, Z., Luo, H., Zhang, L., Huang, Y., Liu, B., Ma, K., Feng, J., Xie, J., Zheng, J., Hu, J., Zhan, S., Zhu, Y., Xu, Q., Kong, W., Wang, X., Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice. Circ. Res. 111 (2012), 1261–1273.
158. [158] Drummond, G.R., Sobey, C.G., Endothelial NADPH oxidases: which NOX to target in vascular disease?. Trends Endocrinol. Metab. 25 (2014), 452–463.
159. [159] Craige, S.M., Chen, K., Pei, Y., Li, C., Huang, X., Chen, C., Shibata, R., Sato, K., Walsh, K., Keaney, J.F. Jr., NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 124 (2011), 731–740.
160. [160] Sánchez-Gómez, F.J., Calvo, E., Bretón-Romero, R., Fierro-Fernández, M., Anilkumar, N., Shah, A.M., Schröder, K., Brandes, R.P., Vázquez, J., Lamas, S., NOX4-dependent Hydrogen peroxide promotes shear stress-induced SHP2 sulfenylation and eNOS activation. Free Radic. Biol. Med. 89 (2015), 419–430.
161. 2. Hypertension 46 (2005), 732–737.
162. [162] Meijles, D.N., Pagano, P.J., Nox and inflammation in the vascular adventitia. Hypertension 67 (2016), 14–19.
163. [163] Hu, Y., Xu, Q., Adventitial biology: differentiation and function. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 1523–1529.
164. [164] Haurani, M.J., Cifuentes, M.E., Shepard, A.D., Pagano, P.J., Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration. Hypertension 52 (2008), 143–149.
165. [165] Liu, J., Ormsby, A., Oja-Tebbe, N., Pagano, P.J., Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy. Circ. Res. 95 (2004), 587–594.
166. [166] Weaver, M., Liu, J., Pimentel, D., Reddy, D.J., Harding, P., Peterson, E.L., Pagano, P.J., Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery. Am. J. Physiol. Heart Circ. Physiol. 290 (2006), H1933–41.
167. [167] Liu, C.F., Zhang, J., Shen, K., Gao, P.J., Wang, H.Y., Jin, X., Meng, C., Fang, N.Y., Adventitial gene transfer of catalase attenuates angiotensin II-induced vascular remodeling. Mol. Med. Rep. 11 (2015), 2608–2614.